ClinicalTrials.Veeva

Menu

Monitorings the Physiological Mechanism of Airway Pressure Release Ventilation in ARDS Patients by EIT

H

Huazhong University of Science and Technology

Status

Enrolling

Conditions

Electrical Impedance Tomography
ARDS

Study type

Observational

Funder types

Other

Identifiers

NCT05406427
EIT20220109

Details and patient eligibility

About

Effects of airway pressure release ventilation on pulmonary ventilation, shunt and perfusion in patients with ARDS

Full description

Effects of airway pressure release ventilation on respiratory mechanisms including ventilation distribution, intrapulmonary shunt and V/Q match in lungs of ARDS evaluated by EIT at different time points.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. 18 years old < age < 80 years old
  2. Diagnosed as moderate or severe ARDS according to the Berlin 2014 definition
  3. Predicted APRV mechanical ventilation for more than 72 hours

Exclusion criteria

Excluded if any of the following exclusion criteria are met:

  1. APRV contraindications such as pneumothorax, severe chronic obstructive pulmonary disease, severe asthma, intracranial hypertension
  2. Pregnant women
  3. Severe cardiac dysfunction (New York Heart Association class III or IV, acute coronary syndrome or sustained ventricular tachyarrhythmia), right heart enlargement due to chronic cardiopulmonary disease, cardiogenic shock or cardiac hand
  4. Refractory shock
  5. BMI>35

Trial design

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

xiaojing zou, PhD; xin zhao, master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems